Determining clinically important changes in range of motion in patients with dupuytrens contracture: Secondary analysis of the randomized, double-blind, placebo-controlled CORD i study

Clinical Drug Investigation

Volumn 31, Issue 11, 2011, Pages 791-798

  Witthaut, Jörg ^a   Bushmakin, Andrew G ^b   Gerber, Robert A ^b   Cappelleri, Joseph C ^b   Le Graverand Gastineau, Marie Pierre Hellio ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b PFIZER INC   (United States)

Author keywords

Collagenase clostridium histolyticum; Dupuytrens contracture; Musculoskeletal disorders

Indexed keywords

CLOSTRIDIOPEPTIDASE A; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL EFFECTIVENESS; CLINICALLY IMPORTANT DIFFERENCE; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DUPUYTREN CONTRACTURE; FEMALE; GONIOMETRY; HAND FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; METACARPOPHALANGEAL JOINT; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PRIORITY JOURNAL; PROXIMAL INTERPHALANGEAL JOINT; RANDOMIZED CONTROLLED TRIAL; RANGE OF MOTION; TREATMENT DURATION; TREATMENT RESPONSE;

AGED; ARTHROMETRY, ARTICULAR; CLOSTRIDIUM HISTOLYTICUM; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; DUPUYTREN CONTRACTURE; FEMALE; FINGERS; HUMANS; MALE; MICROBIAL COLLAGENASE; MIDDLE AGED; PATIENT SATISFACTION; PLACEBOS; RANGE OF MOTION, ARTICULAR; TIME FACTORS; TREATMENT OUTCOME;

EID: 80053518308     PISSN: 11732563     EISSN: 11791918     Source Type: Journal    
DOI: 10.1007/bf03256918     Document Type: Article

References (14)

1. Yost J, Winters T, Fett HS. Dupuytrens contracture: a statistical study. Am J Hand Surg 1955; 90: 568-71
2. Dias JJ, Braybrooke J. Dupuytrens contracture: an audit of the outcomes of surgery. J Hand Surg (Edinburgh, Scotland) 2006 Oct; 31 (5): 514-21 (Pubitemid 44321360)
3. Ellis B, Bruton A. A study to compare the reliability of composite finger flexion with goniometry for measurement of range of motion in the hand. Clin Rehabil 2002 Aug; 16 (5): 562-70
4. Badalamente MA, Hurst LC. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytrens contracture. J Hand Surg Am 2007 Jul-Aug; 32 (6): 767-74 (Pubitemid 46991162)
5. Gilpin D, Coleman S, Hall S, et al. Injectable collagenase clostridium histolyticum: a new nonsurgical treatment for Dupuytrens contracture. J Hand Surg Am 2010; 35A: 2027-38
6. Hurst LC, Badalamente MA, Hentz VR, et al. Injectable collagenase clostridium histolyticum for Dupuytrens contracture. N Engl J Med 2009 Sep 3; 361 (10): 968-79
7. Crosby RD, Kolotkin RL, Williams GR. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol 2003; 56 (5): 395-407 (Pubitemid 36694091)
8. Guyatt GH, OsobaD,Wu AW, et al. Methods to explain the clinical significance of health status measures. Mayo Clin Proc 2002 Apr; 77 (4): 371-83 (Pubitemid 34260746)
9. Bennett RM, Bushmakin AG, Cappelleri JC, et al. Minimal clinically important difference in the fibromyalgia impact questionnaire. J Rheumatol 2009 Jun; 36 (6): 1304-11
10. Cappelleri JC, Bushmakin AG, McDermott AM, et al. Measurement properties of the Medical Outcomes Study Sleep Scale in patients with fibromyalgia. Sleep Med 2009 Aug; 10 (7): 766-70
11. Lauridsen HH, Hartvigsen J, Manniche C, et al. Responsiveness and minimal clinically important difference for pain and disability instruments in low back pain patients. BMC Musculoskelet Disord 2006; 7: 82-98
12. Mulhall JP, King R, Kirby M, et al. Evaluating the sexual experience in men: validation of the sexual experience questionnaire. J Sex Med 2008 Feb; 5 (2): 365-76 (Pubitemid 351167744)
13. Coyne KS, Matza LS, Thompson CL, et al. Determining the importance of change in the overactive bladder questionnaire. J Urol 2006 Aug; 176 (2): 627-32 (Pubitemid 43927875)
14. Farrar JT, Young Jr JP, LaMoreaux L, et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001 Nov; 94 (2): 149-58 (Pubitemid 33016608)